4.3 Article

ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration

期刊

ONCOTARGET
卷 8, 期 49, 页码 85068-85084

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.18844

关键词

ACKR3; CXCR4; chemokine; B cell; lymphoma

资金

  1. Krebsforschung Schweiz [KFS 2891-02-2012]
  2. Swiss National Science Foundation [310030_163336]
  3. Helmut Horten Foundation
  4. Gelu Foundations
  5. Swiss National Science Foundation (SNF) [310030_163336] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Diffuse large B cell lymphoma (DLBCL) is the most frequent lymphoma accounting for more than the 30% of the cases. Involvement of extranodal sites, such as bone marrow and central nervous system, is associated with poor prognosis. A contribution of the chemokine system in these processes is assumed as it is known as a critical regulator of the metastatic process in cancer. The atypical chemokine receptor 3 (ACKR3), which does not couple to G-proteins and does not mediate cell migration, acts as a scavenger for CXCL11 and CXCL12, interfering with the tumor homing CXCL12/CXCR4 axis. Here, functional expression of ACKR3 in DLBCL cells was necessary for colonization of the draining lymph node in an in vivo subcutaneous lymphoma model. Moreover, in a disseminated in vivo lymphoma model, ACKR3 expression was required for bone marrow and brain invasion and local tumor growth. The present data unveil ACKR3 as potential therapeutic target for the control of tumor dissemination in DLBCL.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据